TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
TCL Archive Senate Committee Approves $1.74 Billion for NCI, Seeks Activation of Dietary Intervention Trial October 19, 1990
